Virtu Financial LLC Autolus Therapeutics PLC Transaction History

Virtu Financial LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$2.32 - $3.36 $32,201 - $46,636	13,880 New	13,880 $32,000
Q1 2022 May 17, 2022	SELL	$3.52 - $5.46 $59,385 - $92,115	-16,871 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$5.1 - $7.0 $86,042 - $118,097	16,871 New	16,871 $88,000
Q3 2021 Nov 12, 2021	SELL	$5.32 - $7.37 $691,105 - $957,414	-129,907 Closed	0 $0
Q2 2021 Sep 17, 2021	BUY	$4.78 - $7.96 $620,955 - $1.03 Million	129,907 New	129,907 $863,000

104

163M

2.8K

13.4K

Ticker AUTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 90,909,800
Market Cap $205M
Description
Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer. The company's clinical-stage programs include obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell investigational therapy that is in Phase 1b/2 clinical trial for the treatment of adult ALL; AUTO1/22, which...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.